Merck’s KEYTRUDA® (pembrolizumab) Approved in China in Combination With Chemotherapy as Neoadjuvant Treatment, Then Continued as Monotherapy After Surgery as Adjuvant Treatment for Patients With Resectable Stage II, IIIA or IIIB NSCLC
This approval marks the fourth non-small cell lung cancer (NSCLC) indication and the first indication in earlier stages of NSCLC for KEYTRUDA in China RAHWAY, N.J.–(BUSINESS... Read more.
Biocytogen Announces Adcendo ApS Exercises Antibody Option to Accelerate ADC Development
Adcendo exercises its option to utilize Biocytogen’s fully human antibodies to further expand its ADC pipeline for cancers with high unmet medical need This collaboration... Read more.
Broadband Service Providers Accelerate Deployments With New Certification Program
First vendors achieve certification by blending G.hn Access with XGS-PON extension FREMONT, Calif.–(BUSINESS WIRE)–A new fiber extension certification... Read more.
FICO Wins Banking Tech Award for Blockchain and AI Innovation
FICO’s use of blockchain for AI model governance wins Tech of the Future: Blockchain and Tokenisation award LONDON–(BUSINESS WIRE)–At the Banking Tech... Read more.
State Street Appoints Majed Al Hassoun as Head of KSA and Bahrain
RIYADH, Saudi Arabia–(BUSINESS WIRE)–State Street Corporation (NYSE: STT) today announced the appointment of Majed Al Hassoun as Country Head Saudi Arabia... Read more.
Circus and Vytal Forge Global Partnership to Pioneer a Sustainable Packaging System for the AI-Powered CA-1 Robot
Vytal operates in 22 countries with 7,000+ partners and recently expanded to the U.S., aligning with Circus global mass-production rollout plans for the CA-1 robot... Read more.
PureTech’s Deupirfenidone (LYT-100) Slowed Lung Function Decline in People with Idiopathic Pulmonary Fibrosis (IPF) as Measured by Forced Vital Capacity (FVC), Achieving the Primary and Key Secondary Endpoints in the ELEVATE IPF Phase 2b Trial
Dose-ranging trial evaluated deupirfenidone 550 mg three times a day (TID) (approximately equivalent exposure to pirfenidone 801 mg TID1) and deupirfenidone 825... Read more.
ViroCell Biologics Expands U.S. Business Development Team With Two New Appointments
Meredith Brown and Elaine Rihn bring strong commercial expertise in cell and gene therapy to roles focused on driving ViroCell’s continued growth LONDON &... Read more.
Akoustis to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
Committed to Full Continuity in Delivering Next-Generation BAW High-Band RF Filters to Customers Around the World Filing to Ensure Business Sold Free and Clear of... Read more.
2024 Design Intelligence Award Ceremony Held with Great Splendor
HANGZHOU, China–(BUSINESS WIRE)–The 2024 Design Intelligence Award (DIA) ceremony took place on December 6 at the China Academy of Art Liangzhu Campus.... Read more.